WO2015180804A1 - Procédé et appareil pour le traitement de la température d'un corps - Google Patents
Procédé et appareil pour le traitement de la température d'un corps Download PDFInfo
- Publication number
- WO2015180804A1 WO2015180804A1 PCT/EP2014/079312 EP2014079312W WO2015180804A1 WO 2015180804 A1 WO2015180804 A1 WO 2015180804A1 EP 2014079312 W EP2014079312 W EP 2014079312W WO 2015180804 A1 WO2015180804 A1 WO 2015180804A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- temperature
- pad
- fluid
- cooling
- modulation scheme
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title claims description 56
- 238000000034 method Methods 0.000 title claims description 27
- 238000001816 cooling Methods 0.000 claims abstract description 127
- 239000012530 fluid Substances 0.000 claims abstract description 104
- 238000010438 heat treatment Methods 0.000 claims abstract description 84
- 241000282414 Homo sapiens Species 0.000 claims description 16
- 238000010792 warming Methods 0.000 claims description 15
- 241001465754 Metazoa Species 0.000 claims description 5
- 238000005086 pumping Methods 0.000 claims description 4
- 208000024891 symptom Diseases 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims 1
- 230000001960 triggered effect Effects 0.000 claims 1
- 230000017531 blood circulation Effects 0.000 description 34
- 210000001519 tissue Anatomy 0.000 description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 208000002193 Pain Diseases 0.000 description 25
- 230000036407 pain Effects 0.000 description 21
- 238000010586 diagram Methods 0.000 description 17
- 230000000694 effects Effects 0.000 description 17
- 230000001965 increasing effect Effects 0.000 description 15
- 230000009467 reduction Effects 0.000 description 15
- 230000006870 function Effects 0.000 description 13
- 238000002560 therapeutic procedure Methods 0.000 description 13
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 230000004087 circulation Effects 0.000 description 11
- 208000014674 injury Diseases 0.000 description 10
- 230000008961 swelling Effects 0.000 description 10
- 230000008901 benefit Effects 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000007789 gas Substances 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 230000009286 beneficial effect Effects 0.000 description 7
- 238000007906 compression Methods 0.000 description 7
- 230000006835 compression Effects 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 230000004060 metabolic process Effects 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 230000001739 rebound effect Effects 0.000 description 7
- 238000001356 surgical procedure Methods 0.000 description 7
- 230000008733 trauma Effects 0.000 description 7
- 230000024883 vasodilation Effects 0.000 description 7
- 230000008859 change Effects 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 5
- 230000000740 bleeding effect Effects 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 230000035876 healing Effects 0.000 description 5
- 230000028709 inflammatory response Effects 0.000 description 5
- 230000001926 lymphatic effect Effects 0.000 description 5
- 238000012423 maintenance Methods 0.000 description 5
- 210000000929 nociceptor Anatomy 0.000 description 5
- 230000003134 recirculating effect Effects 0.000 description 5
- 230000006978 adaptation Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate Chemical compound CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC JXSJBGJIGXNWCI-UHFFFAOYSA-N 0.000 description 4
- 230000001815 facial effect Effects 0.000 description 4
- 238000003825 pressing Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 210000004872 soft tissue Anatomy 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000000015 thermotherapy Methods 0.000 description 4
- 208000008035 Back Pain Diseases 0.000 description 3
- 208000000094 Chronic Pain Diseases 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 206010047139 Vasoconstriction Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000025033 vasoconstriction Effects 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 208000001034 Frostbite Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 208000028389 Nerve injury Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000001264 anterior cruciate ligament Anatomy 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000000315 cryotherapy Methods 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 230000000004 hemodynamic effect Effects 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000008764 nerve damage Effects 0.000 description 2
- 230000014653 neuromuscular process Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000009894 physiological stress Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 208000012514 Cumulative Trauma disease Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010015866 Extravasation Diseases 0.000 description 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 206010023201 Joint contracture Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010027603 Migraine headaches Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000037486 Postoperative Hemorrhage Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000000491 Tendinopathy Diseases 0.000 description 1
- 206010043255 Tendonitis Diseases 0.000 description 1
- 206010047141 Vasodilatation Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000000746 body region Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000036251 extravasation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000030214 innervation Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000013532 laser treatment Methods 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 229940124583 pain medication Drugs 0.000 description 1
- 230000037324 pain perception Effects 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 201000004415 tendinitis Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000011883 total knee arthroplasty Methods 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0054—Heating or cooling appliances for medical or therapeutic treatment of the human body with a closed fluid circuit, e.g. hot water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0086—Heating or cooling appliances for medical or therapeutic treatment of the human body with a thermostat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0093—Heating or cooling appliances for medical or therapeutic treatment of the human body programmed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0282—Compresses or poultices for effecting heating or cooling for particular medical treatments or effects
- A61F2007/0284—Treatment of stings or bites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0282—Compresses or poultices for effecting heating or cooling for particular medical treatments or effects
- A61F2007/0285—Local anaesthetic effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0282—Compresses or poultices for effecting heating or cooling for particular medical treatments or effects
- A61F2007/029—Fat cell removal or destruction by non-ablative heat treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
- A61F2007/0295—Compresses or poultices for effecting heating or cooling for heating or cooling or use at more than one temperature
- A61F2007/0296—Intervals of heating alternated with intervals of cooling
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Thermal Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
Abstract
L'invention concerne un appareil (100) comprenant :-un système de refroidissement actif (200) et un système de chauffage actif (500) influençant la température du fluide (F) d'un système de fluide (111),-un dispositif de commande (300) pour faire fonctionner ledit système de refroidissement (200) et système de chauffage (500), et au moins une plaquette (400) pouvant être reliée audit système de fluide (111) de sorte que le fluide (F) peut être amené à s'écouler à travers ladite plaquette (400), où le dispositif de commande (300) est mis en œuvre ou programmé pour exécuter un schéma de modulation prédéfini, ledit schéma de modulation comprenant une phase de refroidissement au cours de laquelle le système de refroidissement (200) est actionné afin de réduire la température du fluide (F) et une phase de chauffage durant laquelle le système de chauffage (500) est actionné afin d'augmenter la température du fluide (F), et où le dispositif de commande (300) maintient la plage de température de la plaquette (400) entre 5°C et 42°C et, de préférence, entre 8°C et 38°C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14827231.3A EP3148489A1 (fr) | 2014-05-29 | 2014-12-24 | Procédé et appareil pour le traitement de la température d'un corps |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14170454.4 | 2014-05-29 | ||
| EP14170454 | 2014-05-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2015180804A1 true WO2015180804A1 (fr) | 2015-12-03 |
Family
ID=50842131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2014/079312 WO2015180804A1 (fr) | 2014-05-29 | 2014-12-24 | Procédé et appareil pour le traitement de la température d'un corps |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP3148489A1 (fr) |
| WO (1) | WO2015180804A1 (fr) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017136958A1 (fr) * | 2016-02-10 | 2017-08-17 | Dmt Desarrollo Tecnologico Medico Spa. | Dispositif de régulation thermique d'une surface corporelle |
| WO2018165552A1 (fr) | 2017-03-10 | 2018-09-13 | Tectraum, Inc. | Système et procédé de traitement de lésion cérébrale |
| WO2019022955A1 (fr) * | 2017-07-28 | 2019-01-31 | Kci Licensing, Inc. | Systèmes et procédé pour thérapie par contraste de température |
| WO2019042635A1 (fr) * | 2017-08-30 | 2019-03-07 | Ener-C Ag | Échangeur de chaleur pour dispositif de traitement thermique d'un corps et dispositif équipé d'un tel échangeur de chaleur |
| CN109701164A (zh) * | 2019-01-12 | 2019-05-03 | 烯旺新材料科技股份有限公司 | 一种理疗设备 |
| US11141309B2 (en) | 2019-06-03 | 2021-10-12 | Cooler Heads Care, Inc. | Cooling cap assembly and cooling unit |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE8334659U1 (de) * | 1983-12-02 | 1986-03-06 | Gembrys, Paul Richard, 6990 Bad Mergentheim | Vorrichtung zur therapeutischen Temperierung von Körperpartien |
| DE202006020386U1 (de) * | 2006-12-08 | 2008-07-17 | Kipper, Manuela | Einrichtung zum Betrieb einer kombinierten Heiz- und Kühleinrichtung |
| WO2013013059A1 (fr) * | 2011-07-20 | 2013-01-24 | Scr Inc. | Systèmes, dispositifs et procédés de chauffage et de refroidissement pour athlètes |
| WO2014165674A1 (fr) * | 2013-04-03 | 2014-10-09 | Sunbeam Products, Inc. | Système de sommeil réparateur |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011343564B2 (en) * | 2010-12-16 | 2016-09-29 | Scion NeuroStim, Inc. | Systems, devices and methods for bilateral caloric vestibular stimulation |
-
2014
- 2014-12-24 WO PCT/EP2014/079312 patent/WO2015180804A1/fr active Application Filing
- 2014-12-24 EP EP14827231.3A patent/EP3148489A1/fr not_active Ceased
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE8334659U1 (de) * | 1983-12-02 | 1986-03-06 | Gembrys, Paul Richard, 6990 Bad Mergentheim | Vorrichtung zur therapeutischen Temperierung von Körperpartien |
| DE202006020386U1 (de) * | 2006-12-08 | 2008-07-17 | Kipper, Manuela | Einrichtung zum Betrieb einer kombinierten Heiz- und Kühleinrichtung |
| WO2013013059A1 (fr) * | 2011-07-20 | 2013-01-24 | Scr Inc. | Systèmes, dispositifs et procédés de chauffage et de refroidissement pour athlètes |
| CN103763956A (zh) * | 2011-07-20 | 2014-04-30 | Scr有限公司 | 运动员的冷却和加热系统、装置和方法 |
| WO2014165674A1 (fr) * | 2013-04-03 | 2014-10-09 | Sunbeam Products, Inc. | Système de sommeil réparateur |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017136958A1 (fr) * | 2016-02-10 | 2017-08-17 | Dmt Desarrollo Tecnologico Medico Spa. | Dispositif de régulation thermique d'une surface corporelle |
| US11458039B2 (en) | 2017-03-10 | 2022-10-04 | Tectraum, Inc. | System and method for treating brain injury |
| CN110621267A (zh) * | 2017-03-10 | 2019-12-27 | 泰科特劳姆股份有限公司 | 用于治疗脑损伤的系统和方法 |
| EP3592309A4 (fr) * | 2017-03-10 | 2021-03-10 | Tectraum, Inc. | Système et procédé de traitement de lésion cérébrale |
| CN110621267B (zh) * | 2017-03-10 | 2022-04-19 | 泰科特劳姆股份有限公司 | 用于治疗脑损伤的系统和方法 |
| WO2018165552A1 (fr) | 2017-03-10 | 2018-09-13 | Tectraum, Inc. | Système et procédé de traitement de lésion cérébrale |
| WO2019022955A1 (fr) * | 2017-07-28 | 2019-01-31 | Kci Licensing, Inc. | Systèmes et procédé pour thérapie par contraste de température |
| US11737913B2 (en) | 2017-07-28 | 2023-08-29 | Kci Licensing, Inc. | Systems and methods for temperature-contrast therapy |
| WO2019042635A1 (fr) * | 2017-08-30 | 2019-03-07 | Ener-C Ag | Échangeur de chaleur pour dispositif de traitement thermique d'un corps et dispositif équipé d'un tel échangeur de chaleur |
| CN109701164A (zh) * | 2019-01-12 | 2019-05-03 | 烯旺新材料科技股份有限公司 | 一种理疗设备 |
| CN109701164B (zh) * | 2019-01-12 | 2024-02-23 | 烯旺新材料科技股份有限公司 | 一种理疗设备 |
| US11141309B2 (en) | 2019-06-03 | 2021-10-12 | Cooler Heads Care, Inc. | Cooling cap assembly and cooling unit |
| US11622881B2 (en) | 2019-06-03 | 2023-04-11 | Cooler Heads Care, Inc. | Cooling cap assembly and cooling unit |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3148489A1 (fr) | 2017-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20170049616A1 (en) | Thermal contrast therapy systems, devices, and methods | |
| WO2015180804A1 (fr) | Procédé et appareil pour le traitement de la température d'un corps | |
| US9532899B2 (en) | Devices and systems for stimulation of tissue | |
| US10935174B2 (en) | Stress relief couplings for cryotherapy apparatuses | |
| US6023932A (en) | Topical cooling device | |
| US8433403B2 (en) | Systems and methods of powered muscle stimulation using an energy guidance field | |
| US20180369064A1 (en) | Devices and methods for increased blood flow, healing, and pain control | |
| Hanks et al. | Physical agent modalities in physical therapy and rehabilitation of small animals | |
| US20170128258A1 (en) | Cryotherapy devices and methods with alternating cooling and heating to limit ischemic injury and to enhance wound healing | |
| CA2877125C (fr) | Dispositifs et systemes de stimulation des tissus | |
| WO2013102056A1 (fr) | Systèmes et procédés de modification de la température corporelle des mammifères | |
| Heinrichs | Superficial thermal modalities | |
| Steiss et al. | Physical agent modalities | |
| CN114533519B (zh) | 用于疼痛控制和康复的系统、方法和设备 | |
| US20120239122A1 (en) | Apparatus and method for hot-cold contrast therapy | |
| Nanneman | Thermal modalities: Heat and gold: A review of physiologic effects with clinical applications | |
| US20180125703A1 (en) | Core body temperature management of an anesthetized patient | |
| Tomlinson et al. | Modalities Part 1: Thermotherapy | |
| US20200170832A1 (en) | Thermal contrast therapy systems, devices, and methods | |
| Ajibola et al. | Design and Fabrication of a Moist Heat Therapy Device for Treating Non-specific Low Back Pain. | |
| WO2020047175A1 (fr) | Dispositifs et méthodes de soulagement de la douleur | |
| RU100394U1 (ru) | Устройство для локальной криотерапии | |
| CN211188204U (zh) | 一种满药腰腹理疗器 | |
| RU2641850C2 (ru) | Термоэлектрическое полупроводниковое устройство для массажа шейно-воротниковой зоны | |
| Cameron | Diathermy: The ideal therapeutic heating modality |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14827231 Country of ref document: EP Kind code of ref document: A1 |
|
| REEP | Request for entry into the european phase |
Ref document number: 2014827231 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2014827231 Country of ref document: EP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |